Skip to content
Homepage
Treatment Guide

Dysautonomia Treatment

Emerging evidence base
Written by Health Writer & Ops
Edited by Freelance Health Writer
Reviewed by Expert in Regenerative & Longevity Medicine, Bioidentical Hormone Therapy, and Pediatric Precision Health

Regenerative approaches that look past symptom control to the upstream drivers of autonomic dysfunction: post-viral autoimmunity, connective tissue laxity, blood volume problems, and mast cell activity.

How does regenerative dysautonomia treatment work?

The autonomic nervous system has two branches that normally work in balance: the sympathetic branch, which speeds things up under demand, and the parasympathetic branch, which handles rest and recovery. In dysautonomia, that balance breaks down. The body can't smoothly adjust blood pressure and heart rate to changing demands, so standing, eating, or exertion can trigger lightheadedness, racing heart, fatigue, or fainting.

Conventional care manages those symptoms directly, and for many people it helps. The regenerative approach adds a second question: what pushed the system out of balance in the first place? The usual suspects are post-viral autoimmunity, connective tissue laxity, problems with blood volume regulation, and mast cell overactivity. Treatment aims at those drivers, not just the standing symptoms.

What conditions is it used for?

  • Postural orthostatic tachycardia syndrome (POTS)

  • Neurocardiogenic and vasovagal syncope

  • Orthostatic hypotension

  • Autonomic neuropathy

  • Post-viral dysautonomia, including Long COVID

  • Dysautonomia linked to Ehlers-Danlos syndrome and hypermobility

"Don't get too caught up in the dysautonomia label. We have to treat the stress-response system as a whole, and that's when the dysautonomia can improve over time." (Dr. Andrew Neville)

What to expect during treatment

Diagnosis usually starts with a simple orthostatic challenge: a clinician measures heart rate and blood pressure lying down, then standing, sometimes using a tilt table test that does the same thing in a controlled way. Heart rate variability, the beat-to-beat variation that reflects autonomic balance, is often tracked too. A thorough workup also screens for triggers and comorbidities: a recent viral illness, joint hypermobility, or signs of mast cell activation.

Treatment is staged and measured in months, not weeks. Most plans start with foundational changes (fluids, salt, sleep position, paced activity), layer in symptom relief, and add driver-directed therapy where a trigger is identified. Clinicians track orthostatic numbers, symptom diaries, and functional capacity to see whether the system is recalibrating.

The Regenerative Medicine Approach (in depth)

Functional and regenerative medicine treats dysautonomia as a symptom of something upstream rather than a condition that exists on its own. The autonomic nervous system rarely fails at random. It is usually responding to a specific insult, and the regenerative approach works backward to find it.

Four upstream patterns account for most cases. Post-infectious autoimmunity, following infections like Epstein-Barr virus, COVID, influenza, or Lyme, can leave the immune system attacking autonomic nerves. Connective tissue laxity, as in Ehlers-Danlos syndrome, destabilizes the structures around the brainstem and blood vessels where autonomic control sits. Problems with blood volume and salt handling reduce the circulating volume the system needs. And mast cell activation, the immune cells that release histamine, can crosswire with autonomic pathways.

Conventional management with beta blockers, midodrine, and fludrocortisone helps many people function, but it does not reach these drivers, which is part of why getting a POTS diagnosis specifically commonly takes five years or more.

Treatments That May Help

No single therapy resolves dysautonomia. Effective plans combine foundational work, symptom relief, and treatment aimed at the underlying driver. The mix depends on the subtype and on what triggered the dysfunction in the first place. Here are the main approaches clinicians use.

Autonomic reconditioning and graded exercise

Structured exercise programs, often the Levine or CHOP protocols, rebuild the reflexes that regulate blood pressure on standing. They usually begin with recumbent exercise (rowing, cycling, swimming) to avoid the upright challenge, then progress over months. The evidence here is among the strongest for any dysautonomia treatment, though the programs require patience and careful pacing.

Volume expansion with salt and fluid

Increasing sodium (commonly 3 to 10 grams a day) and fluid intake (2 to 3 liters) expands plasma volume without medication. For people with orthostatic intolerance, more circulating volume means less of a drop when they stand. Trials in patients with syncope have shown improved orthostatic tolerance and baroreflex sensitivity after salt loading, with blood pressure monitored along the way. Sodium loading isn't appropriate for everyone. Talk it through with your clinician first if you have high blood pressure, heart failure, or kidney disease.

Vagal tone work and HRV biofeedback

The vagus nerve is the main parasympathetic pathway, and its activity (vagal tone) can be trained. Slow paced breathing, heart rate variability biofeedback, cold exposure, humming, and gargling all aim to strengthen parasympathetic recovery. Early trial data on HRV biofeedback is encouraging; it works as a clinical intervention rather than a simple relaxation technique.

Addressing post-viral and autoimmune drivers

When dysautonomia follows a viral illness, treatment may target the immune dysregulation behind it. Low-dose naltrexone is used off-label for the post-viral autoimmune subtype, drawing on its track record in fibromyalgia and post-viral fatigue. Because evidence into its use to treat dysautonomia is still in the early stages, it should be administered under the care of a clinician experienced in autonomic medicine.

Treating comorbidities (MCAS and EDS)

Dysautonomia, mast cell activation syndrome (MCAS), and Ehlers-Danlos syndrome frequently run together. Roughly a third to half of dysautonomia patients show features of mast cell activation. Stabilizing mast cells or supporting connective tissue through targeted movement and hydration can ease autonomic symptoms when these conditions overlap.

Lifestyle and pacing

Sleep position matters directly: raising the head of the bed four to six inches improves overnight blood volume distribution. Pacing activity to avoid energy crashes, managing stress to reduce sympathetic overdrive, and using compression garments for orthostatic relief are all low-cost measures that support every other treatment.

What the Evidence Supports

The strongest data sits with the non-pharmacological foundations. A study of 178 patients with unexplained syncope found that those with low dietary salt intake had poorer orthostatic tolerance, and salt loading improved both tolerance and baroreflex sensitivity in about 69 percent of those treated (Cooper & Hainsworth, 2002). Plasma volume regulation studies confirm that blood pressure in autonomic failure is unusually dependent on circulating volume (Wilcox et al., 1984), which is the rationale behind both oral and intravenous volume expansion (Snapper & Cheshire, 2022).

Post-viral dysautonomia now has substantial data. A cross-sectional study of 100 Long COVID patients found autonomic dysfunction in 82 percent, and the degree of dysfunction coincided with overall symptom burden (Tamariz et al., 2025). A UK specialist service reported dysautonomia symptoms in 38 percent of Long COVID patients on standing tests (Sivan et al., 2023). Intermittent intravenous saline produced significant symptom improvement in a case series of dysautonomic myalgic encephalomyelitis/chronic fatigue syndrome patients (Sjögren et al., 2025).

Where the Evidence Is Limited

Several widely used approaches rest on borrowed or early evidence. Low-dose naltrexone for post-viral dysautonomia is extrapolated from fibromyalgia and post-viral fatigue research; there are currently no completed dysautonomia-specific randomized trials. Vagal tone interventions show promise, but the trials are small, use varied stimulation methods, and often study other conditions like epilepsy rather than dysautonomia directly.

The bigger limitation is fragmentation. Dysautonomia covers several distinct subtypes with different mechanisms, and a treatment that helps POTS may do little for orthostatic hypotension or autonomic neuropathy. Driver-directed protocols, such as antiviral regimens for suspected Epstein-Barr reactivation, remain largely unproven. The IV saline data, while positive, comes from uncontrolled case series.

Combining Treatments

In practice, clinicians rarely use one approach alone. A typical plan layers three levels:

  • Foundational measures, such as salt, fluid, sleep position, pacing, that create the conditions for recovery;

  • Symptom relief using compression and conventional medications, where needed, that keeps a person functional day to day;

  • Driver-directed work, such as immune-focused therapy and comorbidity treatment, that addresses what started the problem.

The regenerative approach is positioned alongside conventional management, not instead of it. For moderate to severe dysautonomia, medications like beta blockers or midodrine often remain part of the plan while the slower reconditioning and driver work proceeds.

Finding the Right Provider

Dysautonomia is underdiagnosed and care quality varies widely. The ideal provider is an autonomic specialist (often a neurologist or cardiologist with a focus on autonomic disorders) or a functional medicine clinician experienced in post-viral illness. Either way, they should be willing to investigate triggers rather than only prescribe symptom control.

Useful questions to ask:

  • How will you screen for what caused this?

  • Will you check for hypermobility and mast cell involvement?

  • What does the plan look like beyond medication?

Be aware of red flags when choosing a provider, such as a clinician who dismisses dysautonomia as anxiety, who skips the workup for underlying drivers, or who promises a fast cure. Recovery here is gradual, and knowledgeable providers say so.

Takeaway

Dysautonomia is a measurable disruption of the autonomic nervous system, and for most people it improves with the right plan. The strongest evidence supports the most basic foundations: exercise reconditioning, salt and fluid loading, and consistent pacing. Vagal tone training adds a trainable lever, and driver-directed work can help when a specific trigger like post-viral autoimmunity is identified.

The practical path is to get an accurate diagnosis through a proper orthostatic workup, start with the foundational measures, and find a clinician who treats the whole stress-response system rather than one symptom. If you arrived here by searching for a specific dysautonomia subtype, our broader guide to autonomic dysfunction and POTS covers how those pieces fit together.

If you’re looking for a provider, you can browse vetted dysautonomia treatment clinics across the U.S. in our directory.

Frequently asked questions

The questions patients ask most before starting Dysautonomia Treatment.

Most plans start with foundational changes: increased salt and fluid, head-of-bed elevation, and carefully paced activity. From there, a clinician layers in symptom relief (compression garments, sometimes medication) and, where a trigger is found, driver-directed therapy. Structured exercise reconditioning usually continues for three to six months.

Clinicians track objective markers like the heart rate and blood pressure change between lying and standing, alongside symptom diaries and functional capacity (how much you can do before crashing). Improvement is usually gradual and measured over months, not days.

No. Dysautonomia is the umbrella term for autonomic nervous system dysfunction. Simply put: All people with POTS have dysautonomia, but not all people with dysautonomia have POTS. POTS is one subtype, defined by an excessive rise in heart rate on standing. Other types include orthostatic hypotension, vasovagal syncope, and autonomic neuropathy, each with different mechanisms.

It depends on the cause. Post-viral dysautonomia can improve substantially and sometimes resolves, especially with reconditioning and time. Types of dysautonomia tied to permanent connective tissue or nerve changes are usually managed long-term rather than cured, though many people regain a good level of function.

References

Carmona-Torre, F., Mínguez-Olaondo, A., López-Bravo, A., Tijero, B., Grozeva, V., Walcker, M., ... Gómez-Esteban, J. (2022). Dysautonomia in COVID-19 patients: A narrative review on clinical course, diagnostic and therapeutic strategies. Frontiers in Neurology, 13, 886609\.

Cooper, V. L., & Hainsworth, R. (2002). Effects of dietary salt on orthostatic tolerance, blood pressure and baroreceptor sensitivity in patients with syncope. Clinical Autonomic Research, 12(4), 236–241.

Sivan, M., Mckeever, V., Natt, M., & Newton, J. (2023). A global need for more awareness of dysautonomia in postviral syndromes. Journal of Medical Virology, 95(8), e29048.

Sjögren, P., Huhmar, H., Bertilson, B., Bragée, B., & Polo, O. (2025). Beneficial effects of intermittent intravenous saline infusion in dysautonomic patients with myalgic encephalomyelitis/chronic fatigue syndrome: A case-series. Frontiers in Neurology, 16, 1601599\.

Snapper, H., & Cheshire, W. (2022). Oral and intravenous hydration in the treatment of orthostatic hypotension and postural tachycardia syndrome. Autonomic Neuroscience: Basic & Clinical, 241, 102951\.

Tamariz, L., Rozenfeld, I., Iglesias, R., Bast, E., Avecillas, S., Shehadeh, L. A., ... Palacio, A. (2025). Dysautonomia in Long COVID is prevalent and could explain the frequency of symptoms. Clinical Medicine Research, 23(1), 1–9.

Wilcox, C., Puritz, R., Lightman, S., Bannister, R., & Aminoff, M. (1984). Plasma volume regulation in patients with progressive autonomic failure during changes in salt intake or posture. Journal of Laboratory and Clinical Medicine, 104(3), 331–339.

About this article

Written by

Lucinda is a writer and researcher with a deep personal interest in health optimization, shaped by more than 12 years of managing chronic health challenges w...

Edited by

Adrienne Santos-Longhurst is a freelance health writer with more than 20 years of experience crafting content for leading consumer health portals and global ...

Medically reviewed by

Dr. Bronwyn Holmes, MD, FAARFM

Dr. Bronwyn Holmes is a board-certified physician and the founder of Bronwyn MD, a private concierge practice with origins in New York City, now based in Los...

Ready to find a clinic that offers Dysautonomia Treatment?

Browse 0 vetted clinics offering Dysautonomia Treatment across the US. All NPI-verified, physician-confirmed, and OIG clear.